B. Rich

发表

Skin-derived interleukin-7 contributes to the proliferation of lymphocytes in cutaneous T-cell lymphoma.

R. Clark, David A Jones, T. Kupper, 2006, Blood.

IL-20: a new target for the treatment of inflammatory skin disease

B. Rich, 2003, Expert opinion on therapeutic targets.

Identification of autoantigens in psoriatic plaques using expression cloning.

T. Kupper, N. Yawalkar, B. Rich, 2004, The Journal of investigative dermatology.

Visualization and Identification of IL-7 Producing Cells in Reporter Mice

M. Ishii, R. Germain, N. Copeland, 2009, PloS one.

Expression profiles of 151 pediatric low-grade gliomas reveal molecular differences associated with location and histological subtype.

T. Golub, R. Beroukhim, P. Wen, 2015, Neuro-oncology.

Langerhans Cells Are Not Required for the CD8 T Cell Response to Epidermal Self-Antigens 1

K. Hogquist, B. Rich, Laura S. Bursch, 2009, The Journal of Immunology.

Self-Antigens CD 8 T Cell Response to Epidermal Langerhans Cells Are Not Required for the

K. Hogquist, B. Rich, Laura S. Bursch, 2009 .

Maintenance of Peripheral Tolerance through Controlled Tissue Homing of Antigen-Specific T Cells in K14-mOVA Mice 1

M. Boes, T. Kupper, R. Fuhlbrigge, 2009, The Journal of Immunology.

Induction of Th2 cell differentiation in the primary immune response: dendritic cells isolated from adherent cell culture treated with IL-10 prime naive CD4+ T cells to secrete IL-4.

H. Weiner, W. Chen, J. Inobe, 1998, International immunology.

Transgenic expression of interleukin 7 restores T cell populations in nude mice

P. Leder, B. Rich, 1995, The Journal of experimental medicine.

IL-7 overexpression in transgenic mouse keratinocytes causes a lymphoproliferative skin disease dominated by intermediate TCR cells: evidence for a hierarchy in IL-7 responsiveness among cutaneous T cells.

T. Kupper, I. Williams, B. Rich, 1997, Journal of immunology.

Cytokines: IL-20 — a new effector in skin inflammation

T. Kupper, B. Rich, 2001, Current Biology.

Combinatorial approach to identification of tyrphostin inhibitors of cytokine signaling.

Xiao-yi Xiao, B. Rich, B. Safina, 2005, Bioorganic & medicinal chemistry.

Abstract P6-07-14: New method to measure functional HER2-driven signaling activity in primary tumor cells identifies HER2-negative breast cancers with abnormal HER2 signaling activity: New group of patients may benefit from anti-HER2 therapy

Lance G. Laing, I. Macneil, B. Rich, 2017 .

A functional signal profiling test for identifying a subset of HER2-negative breast cancers with abnormally amplified HER2 signaling activity

Lance G. Laing, C. Lange, I. Macneil, 2016, Oncotarget.

T Cell Trafficking Plays an Essential Role in Tumor Immunity

T. Kupper, R. Fuhlbrigge, R. Blumberg, 2018, Laboratory Investigation.

Brigatinib Dose Rationale in Anaplastic Lymphoma Kinase–Positive Non‐Small Cell Lung Cancer: Exposure–Response Analyses of Pivotal ALTA Study

K. Venkatakrishnan, P. Diderichsen, Pingkuan Zhang, 2020, CPT: pharmacometrics & systems pharmacology.

A potential pathway of Th2 development during primary immune response. IL-10 pretreated dendritic cells can prime naive CD4+ T cells to secrete IL-4.

H. Weiner, W. Chen, J. Inobe, 1997, Advances in experimental medicine and biology.

Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease.

M. Perales, M. V. D. van den Brink, J. Halm, 2001, Blood.

Expression of Interleukin-18 and Caspase-1 in Cutaneous T-Cell Lymphoma

R. Clark, David A Jones, T. Kupper, 2006, Clinical Cancer Research.

Development of a test that measures real-time HER2 signaling function in live breast cancer cell lines and primary cells

Lance G. Laing, C. Lange, I. Macneil, 2017, BMC Cancer.

Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1

Liliana Goumnerova, Gad Getz, Rameen Beroukhim, 2013, Proceedings of the National Academy of Sciences.

Interrogation of gossypol therapy in glioblastoma implementing cell line and patient-derived tumour models

K. Ligon, J. Prehn, W. Gallagher, 2014, British Journal of Cancer.

New HER2-negative breast cancer subtype responsive to anti-HER2 therapy identified

Lance G. Laing, I. Macneil, D. Hawkins, 2020, Journal of Cancer Research and Clinical Oncology.

Detection of KIAA1549-BRAF fusion transcripts in formalin-fixed paraffin-embedded pediatric low-grade gliomas.

L. Garraway, K. Ligon, L. Macconaill, 2011, The Journal of molecular diagnostics : JMD.

Absence of oncogenic canonical pathway mutations in aggressive pediatric rhabdoid tumors

L. Garraway, K. Ligon, C. Roberts, 2012, Pediatric blood & cancer.

Cutaneous lymphoproliferation and lymphomas in interleukin 7 transgenic mice

P. Leder, R. Tepper, R. Moreadith, 1993, The Journal of experimental medicine.

Engineering Toxin‐Resistant Therapeutic Stem Cells to Treat Brain Tumors

K. Shah, Daniel W. Stuckey, S. Hingtgen, 2015, Stem cells.

ATYPICAL TERATOID RHABDOID TUMOR (ATRT)

R. Siebert, K. Ligon, C. Roberts, 2012 .

Interleukin-7 induces recruitment of monocytes/macrophages to endothelium.

Lan Li, L. Chan, A. Paul, 2012, European heart journal.

Bioactive IL7-diphtheria fusion toxin secreted by mammalian cells.

B. Rich, S. Shulga-Morskoy, 2005, Protein engineering, design & selection : PEDS.

Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1

A. McKenna, W. Hahn, G. Getz, 2013, Proceedings of the National Academy of Sciences.